Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze PCRX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate PCRX investment potential.

What is PCRX stock price today?

Get real-time PCRX stock price, historical data, and price charts on Financhill. Track PCRX performance with our advanced analysis tools.

Is PCRX a good investment?

Evaluate PCRX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy PCRX stock?

To buy PCRX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of PCRX?

View detailed market capitalization data and company valuation metrics for PCRX on our comprehensive analysis page.

What is the P/E ratio of PCRX?

Use our fundamental analysis tools to view PCRX P/E ratio and compare valuation metrics with industry peers.

What are PCRX earnings?

View PCRX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Pacira Biosciences, Inc. Stock Predictions

Missed $0.81? RAD Intel Now Open at $0.85/Share

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

PCRX
Pacira Biosciences, Inc.

Last Price:

$24.21

Seasonality Move:

14.62%

7 Day Trial

ALL ACCESS PASS

$ 7

Still Time to Get In: RAD Intel at $0.85/Share

Pacira Biosciences, Inc. Stock Forecast

Over the next 52 weeks, Pacira Biosciences, Inc. has on average historically risen by 24.8% based on the past 14 years of stock performance.
Pacira Biosciences, Inc. has risen higher in 7 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Pacira Biosciences, Inc. Stock Undervalued?

The current Pacira Biosciences, Inc. [PCRX] share price is $23.98. The Score for PCRX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
PCRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Pacira Biosciences, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Pacira Biosciences, Inc. has on average historically risen by 24.8% based on the past 14 years of stock performance.

Pacira Biosciences, Inc. Stock Rating

Sell

Pacira Biosciences, Inc. (PCRX) is a Sell

Is Pacira Biosciences, Inc. overpriced?

Pacira Biosciences, Inc. has risen higher in 7 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Pacira Biosciences, Inc. Stock Price History

Is PCRX stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PCRX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

pacira.com

52-Week Data

52-Week High:

27.64

52-Week Low:

18.17

Prediction Charts

Market Cap:

Price in USD:

23.98

Volume:

573.7K

Beta:

0.94

Technical Analysis

SMA50:

23.19

SMA100:

23.98

SMA200:

24.34

52-Wk Change:

25.62%

Stock Predictions

Is Pacira Biosciences, Inc. stock public?

Yes, Pacira Biosciences, Inc. is a publicly traded company.
What is the Pacira Biosciences, Inc. stock quote today?

The Pacira Biosciences, Inc. stock price is 23.98 USD today.
How to buy Pacira Biosciences, Inc. stock online?

You can buy Pacira Biosciences, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-14	23.54	23.78	23.99	23.25
Nov-17	24.09	23.88	24.92	23.63
Nov-18	23.85	24.39	24.58	23.62
Nov-19	24.49	24.33	24.69	23.76
Nov-20	24.55	22.80	24.95	22.77
Nov-21	22.76	23.05	23.29	22.29
Nov-24	23.04	23.16	23.47	22.51
Nov-25	23.16	23.17	23.97	23.00
Nov-26	23.32	23.81	24.18	23.14
Nov-28	24.50	23.57	24.50	23.36
Dec-1	23.49	23.70	24.18	23.29
Dec-2	23.82	24.07	24.33	23.48
Dec-3	24.74	24.19	24.81	23.87
Dec-4	24.13	23.98	24.34	23.90

Pacira Biosciences, Inc. Earnings

Pacira Biosciences, Inc. Earnings Report: Per Share Pacira Biosciences, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Pacira Biosciences, Inc. Forecast Revenue Growth

Pacira Biosciences, Inc. Stock Analysis: Historical quarterly revenues per share for Pacira Biosciences, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.41 per share.

* Pacira Biosciences, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.